We are thrilled to announce that on April 2, 2019, the Vrije Universiteit Brussel (VUB) will award a joint honorary doctorate for scientific excellence to Susie Durie, IMF President and Co-founder, and Brian G.M. Durie, MD, IMF Chairman and Co-founder, at a ceremony in Brussels, Belgium. 

Dr. Brian G.M. Durie will focus on early disease management including criteria for diagnosis and best treatment options. Patients are increasingly diagnosed early and must be certain if decisive first therapy is appropriate or if observation is recommended. With the introduction of new therapies, there are many options to be reviewed and considered for patients in each risk group, including assessment for age and comorbidities. Current best treatment guidelines will be presented.

Our volunteer fundraisers help raise multiple myeloma awareness in their communities while raising much needed funding for our essential research, patient education, support, and advocacy programs.

At the recent VUB Honorary Doctorate Awards Ceremony at the University of Brussels, the focus was on “Figures That Matter.” The word “figures” had a double meaning: numbers and facts, as well as individuals and personalities. Susie and I received the award for scientific research and education in the field of myeloma. The fundamental meaning of the university’s theme for the awards was that knowledge is indeed powerful. It must be sought and communicated. And using knowledge—at all costs—really matters.

In this week’s video, Dr. Brian G.M. Durie discusses the main types of imaging studies for myeloma patients, including MRIs, whole-body low-dose CT scans, and PET/CT scans.